Índice de comorbidades de Charlson no lúpus eritematoso sistêmico em pacientes brasileiras / Charlson's coordinity index in systemic lupus erythematosus in brazilian patients

Introdução: O índice de comorbidades de Charlson (ICC) avalia as chances de sobrevida de uma pessoa nos próximos 10 anos. No lúpus eritematoso sistêmico (LES) múltiplas comorbidades e complicações afetam a sobrevida. Objetivo: Verificar as variáveis que influem no ICC de um grupo de mulheres com LES. Métodos: Estudo retrospectivo de 100 pacientes lúpicas para o ICC, variáveis clínicas, epidemiológicas e sorológicas. Resultados: Nenhuma variável epidemiológica interferiu no ICC. Quanto à clínica, pacientes com glomerulonefrite tiveram pior ICC do que os sem (p<0,0001) e os com manifestações de sistema nervoso central tiveram tendência para pior ICC (p=0,09). Portadores de anticorpos anti-Ro (p=0,02) e fator reumatoide (FR; p=0,002) se associaram com ICC menor. Conclusões: A presença de glomerulonefrite se associa com menor sobrevida, e a dos anticorpos anti-Ro e FR com maior sobrevida no LES.

Introduction: The Charlson comorbidities index (CCI) assesses a person's chances of survival over the next 10 years. In systemic lupus erythematosus (SLE), multiple comorbidities and complications affect patient survival. Objetive: Analize the variables that influence the CCI of a group of females with SLE. Methods: Retrospective study of medical records of 100 lupus patients for CCI, clinical, epidemiological and serological variables. Results: No epidemiological variable interfered in CCI. Regarding clinical manifestations, patients with glomerulonephritis had a worse CCI than those without (p<0.0001) and those with central nervous system manifestations had a tendency to worse CCI (p=0.09). Patients with anti-Ro antibodies (p=0.02) and rheumatoid factor or RF (p=0.002) were associated with a lower CCI. Conclusions: The presence of glomerulonephritis is associated with lower survival and of the anti-Ro and RF antibodies with longer survival in SLE.

Serum immunoglobulin a deficiency and autoimmune comorbidities: a crossectional study in 281 patients with systemic lupus erythematosus

SUMMARY OBJECTIVE To study the profile of associated autoimmune diseases in a series of patients with systemic lupus erythematosus (SLE) and see if such associations are linked to IgA deficiency. METHODS Two hundred eighty-one patients with SLE were studied for Ig A levels by nephelometry. Levels equal to or under 0.05g/dL were considered as IgA deficiency. Epidemiological and clinical data, including the presence of associated autoimmune diseases, were extracted from the patient's charts. RESULTS Ig A deficiency was found in 6% of the patients. In 30.2% of SLE patients, there was at least one more autoimmune disease; Hashimoto thyroiditis and Sjögren's syndrome were the most common. No association between the occurrence of associated autoimmune disease with IgA deficiency was found. CONCLUSIONS There is a high prevalence of autoimmune diseases associated with SLE. IgA deficiency does not affect the presence of these associations.

RESUMO OBJETIVO Estudar o perfil de doenças autoimunes associadas em uma série de pacientes com lúpus eritematoso sistêmico (LES) e verificar se tais associações estão ligadas à deficiência de imunoglobulina (Ig) A. MÉTODOS Foram estudados 281 pacientes com LES para os níveis de IgA por nefelometria. Níveis iguais ou menores que 0,05 g/dL foram considerados como deficiência dessa imunoglobulina. Dados epidemiológicos e clínicos, incluindo a presença de doenças autoimunes associadas, foram extraídos dos prontuários dos pacientes. RESULTADOS A deficiência de IgA foi encontrada em 6% dos pacientes. Em 30,2% dos pacientes com LES encontrou-se a presença de, pelo menos, mais uma doença autoimune. Tireoidite de Hashimoto e síndrome de Sjögren foram as mais comuns. Não foi possível ligar a ocorrência de uma doença autoimune associada ao LES com deficiência de IgA. CONCLUSÕES Existe uma alta prevalência de doenças autoimunes associadas ao LES. A deficiência de IgA não afeta a presença dessas associações.

Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center

Abstract Background: Nephritis occurs frequently in systemic lupus erythematosus (SLE) and may worsen disease morbidity and mortality. Knowing all characteristics of this manifestation helps to a prompt recognition and treatment. Aim: To compare the differences in clinical data, serological profile and treatment response of nephritis of early and late onset. Methods: Retrospective study of 71 SLE patients with biopsy proven nephritis divided in early nephritis group (diagnosis of nephritis in the first 5 years of the disease) and late nephritis (diagnosis of nephritis after 5 years). Epidemiological, serological, clinical and treatment data were collected from charts and compared. Results: In this sample, 70. 4% had early onset nephritis and 29.6% had late onset. No differences were noted in epidemiological, clinical, serological profile, SLICC and SLEDAI, except that late onset nephritis patients were older at nephritis diagnosis (p = 0.01). Regarding renal biopsy classification, C3 and C4 levels, serum creatinine, 24 h proteinuria and response rate to treatment the two groups were similar (p = NS). Patients with early onset had lower levels of hemoglobin at nephritis onset than those of late onset (p = 0.02). Conclusions: Most of SLE patients had nephritis in the first 5 years of disease. No major differences were noted when disease profile or treatment outcome of early and late onset nephritis were compared.(AU)

Sarcoidose e sacroiliíte: relato de caso e revisão da literatura / Sarcoidosis and sacroiliitis: case report and literature review

A sarcoidose é uma doença granulomatosa sistêmica, de etiologia ainda desconhecida. Essa doença pode acometer qualquer órgão, mas afeta principalmente pulmão e gânglios linfáticos intratorácicos. Em apenas 10% dos casos existe envolvimento extra torácico. O envolvimento articular é raro e pode-se dividir em agudo e crônico. As articulações mais afetadas na sarcoidose são as dos joelhos, punho, cotovelo e articulações das mãos e pés. Neste estudo iremos descrever um caso de um paciente com sarcoidose envolvendo a articulação sacriilíaca. O acometimento dessa região é bem raro e existem poucos casos relatados na literatura

Sarcoidosis is a systemic granulomatous disease of unknown etiology. This disease can affect any organ, but prefers lung and intra thoracic lymph nodes. In just 10% of cases there is extra thoracic involvement. Joint involvement is rare and can be divided into acute and chronic involvment. The most affected joints are the knees, wrist, elbow, and joints of the hands and feet. Herein we describe a case of a patient with sarcoidosis involving the sacriiliac joint. The involvement of this region is very rare and there are few cases reported in the literature

Sarcoidose e sacroiliíte: relato de caso e revisão da literatura / Sarcoidosis and sacroiliitis: case report and literature review

A sarcoidose é uma doença granulomatosa sistêmica, de etiologia ainda desconhecida. Essa doença pode acometer qualquer órgão, mas afeta principalmente pulmão e gânglios linfáticos intratorácicos. Em apenas 10% dos casos existe envolvimento extra torácico. O envolvimento articular é raro e pode-se dividir em agudo e crônico. As articulações mais afetadas na sarcoidose são as dos joelhos, punho, cotovelo e articulações das mãos e pés. Neste estudo iremos descrever um caso de um paciente com sarcoidose envolvendo a articulação sacriilíaca. O acometimento dessa região é bem raro e existem poucos casos relatados na literatura

Sarcoidosis is a systemic granulomatous disease of unknown etiology. This disease can affect any organ, but prefers lung and intra thoracic lymph nodes. In just 10% of cases there is extra thoracic involvement. Joint involvement is rare and can be divided into acute and chronic involvment. The most affected joints are the knees, wrist, elbow, and joints of the hands and feet. Herein we describe a case of a patient with sarcoidosis involving the sacriiliac joint. The involvement of this region is very rare and there are few cases reported in the literature

The Brazillian version of the hand mobility in scleroderma (HAMIS) test: translation and validation

Abstract Background: The Hand Mobility in Scleroderma (HAMIS) test was created to measure the degree of dysfunction of hand movements imposed by systemic sclerosis (SSc). The modified version (mHAMIS), with 4 of the 9 original items, was developed later. The goal of the present study was to translate and validate HAMIS and mHAMIS into Brazilian Portuguese and culture. Methods: After direct and reverse translation and comprehension test in 10 SSc patients, HAMIS-Br was applied to another 32 patients with SSc. To evaluate internal consistency, intraobserver and interobserver agreement, and intraobserver and interobserver reliability, we used respectively the Cronbach's α coefficient, kappa concordance and intraclass correlation (ICC). The correlation between HAMIS-Br and mHAMIS-Br was evaluated and a factorial analysis was performed. Results: HAMIS-Br showed excellent internal consistency (Cronbach's α = 0.997), good intraobserver agreement (kappa between 0.78 [95%CI =0.57-0.99] and 1) and intraobserver and interobserver reliability (ICC = 0.993, 95% CI = 0.973-0.993 and ICC = 0.994, 95% CI = 0.987-0.997, respectively). The mHAMIS-Br presented similar results and excellent correlation with HAMIS-Br (r = 0.923). The factorial analysis extracted three groups of questions that explain 84.4% of the total variance, and that can be understood through the influence of certain movements in the interpretation of others: [1] questions whose interpretation is influenced by the extension of the fingers, [2] questions whose interpretation is influenced by flexion of the fingers, [3] volar flexion of the fingers, with similar correlation with both other factors. Conclusions: HAMIS-Br and mHAMIS-Br showed good agreement, intraobserver and interobserver reliability, and internal validity. It is necessary to be attentive to the influence of certain limitations of movements in the interpretation of others.